Tacitus Therapeutics exclusively licenses technology for expansion, differentiation and engineering of hematopoietic stem cells for use in therapeutic applications Tacitus Therapeutics, a clinical-stage company, has launched in collaboration with the Mount Sinai Health System to develop stem cell therapies initially targeting blood cancers and related clotting disorders. …

Mount Sinai Innovation Partners (MSIP) participated in several conferences and events to wrap up 2019, gathering thought leaders and industry experts to discuss best practices on building a strong life science ecosystem for the purpose of helping patient populations. These events included discussions on the future of medicine and trends…

Nines’ unique approach to teleradiology reimagines radiology together with engineering and data science prowess to bring a new level of patient care Nines debuts as the first-of-its-kind teleradiology practice that combines top quality radiologists and world-class engineering to deliver high-quality diagnostics and priority-driven patient care decisions. “We have a fundamental…

The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi. While immunotherapy has revolutionized the field of oncology, there…

Clinic and research lab offers patients access to comprehensive health assessment, expands clinical understanding of disease prevention and provides wealth of health outcomes data Onegevity Health, LLC, a New York City-based health technology company focused on biometric data, artificial intelligence and personalized wellness, has acquired the global licensing rights to…

The Mount Sinai Health System and SAP Foundry in Hudson Yards, New York partnered with other forward-thinking organizations to host the recent installment of The Open Innovation In Healthcare Pop-Up series on October 1. The Pop-Up is a convener for healthcare executives and innovators to gather and pioneer thoughtful conversations…

The inaugural iLABS event took place on September 19, showcasing the latest technologies in ophthalmology from Mount Sinai Health System innovators. …

Sinai BioDesign, an organization of the Icahn School of Medicine at Mount Sinai focused on the development of biomedical technologies, hosted U.S. Food and Drug Administration (FDA) representative Joshua Chetta on October 1 to discuss the regulations and requirements for device submission and review. …

Organizational culture is defined as the underlying beliefs, values, and ways of interacting that contribute to the unique social and psychological environment of an organization. There are various types of organizational culture, but especially in the face of open innovation in health care, an organization will undoubtedly be tested. …